A&G, Mayo Medical sign license agreement for new progranulin blood test for FTD

[News]

Mayo Clinic today announced that Mayo Medical Laboratories has signed an agreement with A&G Pharmaceutical, Inc. and will receive a non-exclusive license to certain patent rights and proprietary antibody reagents for the detection and measurement of progranulin in blood.

More... (http://www.news-medical.net/news/20120307/AG-Mayo-Medical-sign-license-agreement-for-new-progranulin-blood-test-for-FTD.aspx)